The R203M and D377Y mutations of the nucleocapsid protein promote SARS-CoV-2 infectivity by impairing RIG-I-mediated antiviral signaling
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1012886 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Yongkui Li und 18 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Coronavirus Nucleocapsid Proteins, DEAD Box Protein 58. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Open Research Fund Program of the State Key Laboratory of Virology of China, Open Research Fund Program of Guangdong Provincial Key Laboratory of Virology.
Abstract (Originalsprache)
The viral protein mutations can modify virus-host interactions during virus evolution, and thus alter the extent of infection or pathogenicity. Studies indicate that nucleocapsid (N) protein of SARS-CoV-2 participates in viral genome assembly, intracellular signal regulation and immune interference. However, its biological function in viral evolution is not well understood. SARS-CoV-2 N protein mutations were analyzed in Delta, Omicron, and original strains. Two mutations with a methionine (M) residue at site 203 and a tyrosine (Y) residue at site 377 of the N protein were found in Delta strain but not in Omicron and original strains, and promoted SARS-CoV-2 infection therein. Those mutations, R203M and D377Y, enhanced the inhibitory impact of N protein on the impairment of RIG-I-mediated antiviral signaling, such as IRF3 phosphorylation and IFN-β activation. The viral RNA-binding activity of N protein was promoted by these mutations, effectively attenuating the recognition and interaction of RIG-I with viral RNA compared to the original or other variants. The R203M/D377Y mutations thus enhanced the suppressive activity of the N protein on RIG-I-mediated interferon induction both in vitro and in vivo, which in turn promoted viral replication. This study helps to understand the variability of SARS-CoV-2 in regulating host immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Disease, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, China.
- Key Laboratory of Viral Pathogenesis & Infection Prevention and Control (Jinan University), Ministry of Education, Guangzhou, China.
- Department of Immunology and Microbiology, Institute of Medical Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
- Laboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
- The First Affiliated Hospital of Jinan University, Guangzhou, China.
ORCID-Profile: Pan Pan
Förderung
- National Natural Science Foundation of China
- Open Research Fund Program of the State Key Laboratory of Virology of China
- Open Research Fund Program of Guangdong Provincial Key Laboratory of Virology
- R&D Program of Guangzhou Laboratory
- Guangdong Basic and Applied Basic Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
- Fundamental Research Funds for the Central Universities
- Guangzhou Science and Technology Plan Project
Zitieren
APA
Li, Y., Li, M., Xiao, H., Liao, F., Shen, M., Ge, W., Ou, J., Liu, Y., Chen, L., Zhao, Y., Wan, P., Liu, J., Chen, J., Lan, X., Wu, S., Ding, Q., Li, G., Zhang, Q., & Pan, P. (2025). The R203M and D377Y mutations of the nucleocapsid protein promote SARS-CoV-2 infectivity by impairing RIG-I-mediated antiviral signaling. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012886
Vancouver
Li Y, Li M, Xiao H, Liao F, Shen M, Ge W, et al. The R203M and D377Y mutations of the nucleocapsid protein promote SARS-CoV-2 infectivity by impairing RIG-I-mediated antiviral signaling. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1012886
BibTeX
@article{Li2025,
author = {Li, Yongkui and Li, Moran and Xiao, Heng and Liao, Feng and Shen, Miaomiao and Ge, Weiwei and Ou, Junxian and Liu, Yuqing and Chen, Lumiao and Zhao, Yue and Wan, Pin and Liu, Jinbiao and Chen, Jun and Lan, Xianwu and Wu, Shaorong and Ding, Qiang and Li, Geng and Zhang, Qiwei and Pan, Pan},
title = {The R203M and D377Y mutations of the nucleocapsid protein promote SARS-CoV-2 infectivity by impairing RIG-I-mediated antiviral signaling},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1012886}
}
EUVIMED